XML 16 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 28, 2025
Mar. 29, 2024
Operating Activities    
Net (loss) income $ (3,856) $ 9,211
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation of property, plant and equipment 3,959 3,077
Amortization of intangible assets 1,976 651
Provision for uncollectible receivables 1,282 569
Share-based compensation 5,626 5,545
Deferred taxes (3,500) 1,659
Inventory write-downs 1,856 3,589
Non-cash lease expense 1,138 575
Loss on extinguishment of debt 485 0
Other non-cash operating activities, net 110 22
Changes in operating assets and liabilities:    
Accounts receivable (24,899) 15,415
Unbilled receivables (11,693) (15,350)
Inventories (30,947) 5,976
Accounts payable 40,904 (8,841)
Accrued expenses (4,752) 11,341
Advance payments and unearned revenue 26,975 (4,213)
Income taxes payable 175 1,099
Other assets and liabilities (9,629) (8,096)
Net cash (used in) provided by operating activities (4,790) 22,229
Investing Activities    
Purchase of property, plant and equipment (10,703) (1,866)
Purchase of marketable securities 0 (925)
Proceeds from sale of asset held for sale 2,589 0
Acquisition, net of cash acquired (18,150) (32,162)
Net cash used in investing activities (26,264) (34,953)
Financing Activities    
Proceeds from revolver 55,000 33,200
Repayments of revolver (55,000) (33,200)
Proceeds from term loan 75,000 50,000
Repayments of term loan (49,687) (625)
Payments of deferred financing costs (529) (79)
Payments of deferred consideration for acquisitions (5,815) 0
Payments for repurchase of common stock - treasury shares (598) (332)
Payments for taxes related to net settlement of equity awards (942) (690)
Proceeds from issuance of common stock under employee stock plans 156 1,005
Net cash provided by financing activities 17,585 49,279
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 214 (597)
Net (decrease) increase in cash, cash equivalents, and restricted cash (13,255) 35,958
Cash, cash equivalents, and restricted cash, beginning of period 64,934 22,521
Cash, cash equivalents, and restricted cash, end of period 51,679 58,479
Supplemental Cash Flow Information [Abstract]    
Common stock issued in connection with acquisition $ 0 $ 22,331